SBRA - Sabra Health Care REIT, Inc.
NEXT EARNINGS:
May 4, 2026
EPS Est: $0.38
|
Rev Est: $210.2M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$21.33
DETAILS
HIGH:
$22.00
LOW:
$21.00
MEDIAN:
$21.00
CONSENSUS:
$21.33
UPSIDE:
4.00%
Market Cap:
5.17B
Volume:
2,454,900
Avg Volume:
2,827,338
52 Week Range:
15.75-20.7
Sector:
Real Estate
Industry:
REIT - Healthcare Facilities
Beta:
0.65
Last Dividend:
$1.20
Exchange:
NASDAQ
Country:
US
Employees:
50
IPO Date:
2002-04-02
EPS (TTM):
0.64
P/E Ratio:
29.37
Revenue (TTM):
774.63M
Total Assets:
5.49B
Total Debt:
1.26B
Cash & Equiv:
71.54M
Rev Growth (5Y):
5.3%
EPS Growth (5Y):
-0.9%
FCF Growth (5Y):
6.9%
ROCE:
6.4%
Debt/Equity:
0.45
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-12 | $0.38 | $0.38 | 0.0% | $211.9M | $200.1M | +5.9% |
| 2025-11-05 | $0.38 | $0.38 | 0.0% | $190.0M | $202.0M | -5.9% |
| 2025-08-04 | $0.38 | $0.37 | +2.7% | $189.2M | $187.5M | +0.9% |
| 2025-05-05 | $0.37 | $0.36 | +2.8% | $183.5M | $182.5M | +0.6% |
| 2025-02-19 | $0.36 | $0.36 | 0.0% | $182.3M | $178.0M | +2.4% |
| 2024-10-31 | $0.37 | $0.36 | +2.8% | $178.0M | $175.6M | +1.3% |
| 2024-08-07 | $0.36 | $0.35 | +2.9% | $178.5M | $166.0M | +7.5% |
| 2024-05-08 | $0.35 | $0.34 | +2.9% | $172.2M | $162.0M | +6.3% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 774.63M | 703.24M | 647.51M | 624.81M | 569.54M | 598.57M | 668.18M | 623.41M | 405.65M | 260.53M | 238.86M | 183.52M |
| Net Income | 155.61M | 126.71M | 13.76M | (77.61M) | (113.26M) | 138.42M | 69.00M | 279.08M | 158.38M | 70.28M | 79.41M | 46.95M |
| EPS | 0.64 | 0.54 | 0.06 | -0.34 | -0.52 | 0.67 | 0.37 | 1.57 | 1.40 | 0.92 | 1.11 | 0.79 |
| Total Assets | 5.49B | 5.30B | 5.39B | 5.75B | 5.97B | 5.99B | 6.07B | 6.67B | 7.03B | 2.27B | 2.49B | 2.06B |
| Total Debt | 1.26B | 2.44B | 2.45B | 2.55B | 2.44B | 2.43B | 2.48B | 3.23B | 3.39B | 1.21B | 1.40B | 1.09B |
| Cash & Equivalents | 71.54M | 60.47M | 41.28M | 49.31M | 112.00M | 65.52M | 49.14M | 50.23M | 518.63M | 25.66M | 7.43M | 61.79M |
| Operating Cash Flow | 348.61M | 310.54M | 300.57M | 315.73M | 356.39M | 354.85M | 372.48M | 358.54M | 133.49M | 176.74M | 121.10M | 85.34M |
| Free Cash Flow | 348.61M | 310.54M | 300.57M | 315.73M | 322.78M | 249.26M | 372.48M | 451.89M | (200.64M) | 176.74M | 121.10M | 85.34M |
| FCF per Share | 1.44 | 1.33 | 1.30 | 1.37 | 1.47 | 1.21 | 1.99 | 2.53 | -1.90 | 2.71 | 1.95 | 1.84 |
| Book Value | 2.82B | 2.74B | 2.80B | 3.06B | 3.38B | 3.41B | 3.49B | 3.25B | 3.43B | 1.02B | 1.05B | 941.87M |
| Cash & ST Investments | 71.54M | 60.47M | 41.28M | 49.31M | 112.00M | 65.52M | 49.14M | 50.23M | 518.63M | 25.66M | 7.43M | 61.79M |
| ROC Equity | 0.06 | 0.05 | 0.00 | -0.03 | -0.03 | 0.04 | 0.02 | 0.09 | 0.05 | 0.07 | 0.08 | 0.05 |